Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 232.00
+21.00 (9.95%)
Sep 25, 2025, 12:52 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 55.49 billion as of September 24, 2025. Its market cap has decreased by -25.76% in one year.
Market Cap
55.49B
Enterprise Value
62.99B
Revenue
19.12B
Ranking
n/a
PE Ratio
11.42
Stock Price
232.00
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 55.49B, an increase of 503.96%. That is a compound annual growth rate of 17.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2025 | 55.49B | -22.42% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | 19.63B | -29.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 302.45B |
| PharmaEssentia | 183.07B |
| Bora Pharmaceuticals Co., LTD. | 85.52B |
| Lumosa Therapeutics | 50.62B |
| Oneness Biotech | 33.10B |
| Polaris Group | 28.20B |
| Center Laboratories | 27.85B |
| Pegavision | 24.77B |